The study was conducted to determine whether the performance of an extended lymphadenectomy and retroperitoneal soft-tissue clearance in association with a pancreatoduodenal resection improves the long-term survival of patients with a potentially curable adenocarcinoma of the head of the pancreas.
Objective
The study was conducted to determine whether the performance of an extended lymphadenectomy and retroperitoneal soft-tissue clearance in association with a pancreatoduodenal resection improves the long-term survival of patients with a potentially curable adenocarcinoma of the head of the pancreas.
Summary Background Data
The usefulness of performing an extended lymphadenectomy and retroperitoneal soft-tissue clearance in conjunction with a pancreatoduodenal resection in the treatment of ductal adenocarcinoma of the head of the pancreas is still unknown. Published studies suggest a benefit for the procedure in terms of better long-term survival rates; however, these studies were retrospective or did not prospectively evaluate large series of patients.
Materials and Methods
Eighty-one patients undergoing a pancreatoduodenal resection for a potentially curable ductal adenocarcinoma of the head of the pancreas were randomized to a standard (n = 40) or extended (n = 41) lymphadenectomy and retroperitoneal soft-tissue clearance in a prospective, multicentric study.
The standard lymphadenectomy included removal of the anterior and posterior pancreatoduodenal, pyloric, and biliary duct, superior and inferior pancreatic head, and body lymph node stations. In addition to the above, the extended lymphadenectomy included removal of lymph nodes from the hepatic hilum and along the aorta from the diaphragmatic hiatus to the inferior mesenteric artery and laterally to both renal hila, with circumferential clearance of the origin of the celiac trunk 508 and superior mesenteric artery. Patients did not receive any postoperative adjuvant therapy.
Results
Demographic (age, gender) and histopathologic (tumor size, stage, differentiation, oncologic clearance) characteristics were similar in the two patient groups. Performance of the extended lymphadenectomy added time to the procedure, although the difference did not reach statistical significance (397 ± 50 minutes vs. 372 ± 50 minutes, p > 0.05). Transfusion requirements, postoperative morbidity and mortality rates, and overall survival did not differ between the two groups. When subgroups of patients were analyzed, using an a posteriori analysis that was not planned at the time of study design, there was a significantly (p < 0.05) longer survival rate in node positive patients after an extended rather than a standard lymphadenectomy. The survival curve of node positive patients after an extended lymphadenectomy could be superimposed onto the curves of node negative patients. Survival curves in node negative patients did not differ according to the magnitude of the lymphadenectomy. Multivariate analysis of all patients showed that long-term survival was affected by tumor differentiation (well vs. moderately vs. poorly differentiated, p > 0.001), diameter (-2.0 cm. vs. > 2.0 cm., p < 0.01), lymph node metastasis (absent vs. present, p < 0.01) and need for 4 or more units of transfused blood (< 4 vs. 2 4, p <0.01).
Conclusions
The addition of an extended lymphadenectomy and retroperitoneal soft-tissue clearance to a pancreatoduodenal resection does not significantly increase morbidity and mortality rates.
Although the overall survival rate does not differ in the two groups, there appears to be a trend toward longer survival in node positive patients treated with an extended rather than a standard lymphadenectomy. To duplicate Ishikawa's study designl', patients were stratified on the basis of tumor size (' or < 4 cm in diameter) and then allocated to standard or extended lymphadenectomy by random numbers generated on a personal computer. The standard lymphadenectomy included removal of the anterior and posterior pancreatoduodenal, pyloric and biliary duct, superior and inferior pancreatic head, and body lymph node stations; in addition to the above, the extended lymphadenectomy included removal of lymph nodes from the hepatic hilum and along the aorta from the diaphragmatic hiatus to the inferior mesenteric artery and laterally to both renal hila, with circumferential clearance of the origin of the celiac trunk and superior mesenteric artery.
Duodenal, bile duct, and pancreatic resection margins were sent for frozen section analysis during the operation. The choice of performing a pancreatoduodenectomy with or without pylorus preservation was left to the preference of the operating surgeon; equally, the surgeon was left free to choose the type of pancreato-jejunal anastomosis. At the end of the procedure, the surgeon indicated whether the oncologic clearance had been complete or whether the tumor could not be resected completely. Because of participation in an overlapping protocol, one of the participants (V. D. C.) was allowed to deliver intraoperative radiotherapy (10-15 Gy) to 19 patients. These 
RESULTS
Eighty-three patients participated in the study: 42 patients were randomized to the standard and 41 patients to the extended lymphadenectomy. Two patients in the standard lymphadenectomy group were subsequently excluded. In one case, the final pathologic diagnosis, confirmed by the two independent reviewers, showed an endocrine pancreatic tumor; in the second case, hepatic metastases, not diagnosed by frozen section at the time of surgical exploration, was diagnosed on permanent sections in the immediate postoperative period. This left 81 patients, 40 in the standard lymphadenectomy and 41 in the extended lymphadenectomy group, to form the basis for this study.
The two groups were similar for demographic (age, gender) and histopathologic (tumor stage, size, proportion of patients whose lymph nodes were positive for tumor, grade, oncologic clearance) characteristics (Table 1 and 2). Although the mean operative time was longer when an extended rather than a standard lymphadenectomy was performed, this difference was not statistically significant ( Table 3) . As expected, lymph node retrieval was higher after an extended lymphadenectomy (19.8 ± 15.1 vs. 13.3 ± 8.3, respectively, p < 0.03). There was no difference in the proportion of patients who required blood transfusions and in the number of units transfused. Although the mean volume of drainage through the abdominal drains was higher in patients after an extended rather than a standard lymphadenectomy, this difference did not reach statistical significance, and the drains were kept in place for a similar length of time. Postoperative length of stay was similar in the two groups. Patients receiving intraoperative radiation therapy were equally allocated to the two groups; a similar proportion of patients in both groups underwent a pyloruspreserving pancreatoduodenectomy.
Twenty-two patients in the standard and 27 in the extended lymphadenectomy group had uneventful postoperative courses. The postoperative morbidity and mortality rates in the remaining 18 patients with standard and 14 with extended lymphadenectomy were similar (Table 4) . Two patients died in each group. In six patients, the immediate postoperative course was complicated by an acute hemoperitoneum. They all underwent reexploration; with the exception of one patient who died of diffuse intravascular coagulopathy after reexploration, all had uneventful postoperative courses. Eight patients developed a pancreatic fistula and one a gastroenterocutaneous fistula; they all healed without requiring further operative treatment. Two subphrenic abscesses successfully were drained percutaneously. As of March 1, 1998 , three patients (all after standard 647) days, respectively. There was no statistically lymphadenectomy) were still alive at 50, 60, and 77 months.
significant difference among the survival curves of patients Overall, actual 1-, 2-3-, and 4-year survival rates were subdivided according to the individual six operating sur-50.6%, 22,2%, 8.6%, and 7.4%, respectively, with no geons (Fig. 2) . statistically significant difference between the survival When survival was analyzed based on the presence or curves of patients after a standard or an extended lymphabsence of metastatic lymph nodes, using an a posteriori adenectomy (Fig. 1 ). Mean and median survival for the analysis that was not planned at the time of study design, standard lymphadenectomy group were 552 (confidence node positive patients had a significantly (p < 0.05) better interval, 364-741) days and 335 (confidence interval 252-survival rate after undergoing an extended rather than a 418) days, respectively; for the extended lymphadenecstandard lymphadenectomy (Fig. 3) . Indeed, the survival tomy group, the corresponding values were 589 (confi-curve of node positive patients after an extended lymphaddence interval, 453-724) and 500 (confidence interval, 353-enectomy closely mimicked the survival curves of node (Fig. 4) , discriminating size of 2 cm (Fig. 5) , lymph node involvement (Fig. 6) , and four or more blood transfusions as independent prognostic variables with standardized regression coefficients of 3.18 (p < 0.001), 2.38 (p <0.01), 2.56 (p < 0.01), and 3.24 (p < 0.01), respectively.
DISCUSSION
The goal of this prospective, randomized, multicenter study was to determine whether the performance of an extended lymphadenectomy with retroperitoneal soft-tissue clearance in association with a pancreatoduodenal resection improved the long-term survival of patients with a potentially curable ductal adenocarcinoma of the head of the pancreas. Overall, our data indicated that there were no significant difference between the survival curves of patients after a standard or extended lymphadenectomy. We also found that performance of an extended lymphadenectomy did not significantly increase morbidity and mortality rates and that the survival rate did not differ significantly by individual surgeon. When we analyzed the survival of patients based on the absence or presence of metastatic lymph nodes, there appeared to be no effect of surgical procedure on node negative patients. However, there appeared to be a trend toward a longer survival in node positive patients who underwent an extended rather than a standard lymphadenectomy. The survival curve of node negative patients after an extended lymphadenectomy could be superimposed to the curves of node negative patients, whereas node positive patients who underwent traditional lymphadenectomy had the worst outcome.
-1 80' In conclusion, we report on the first prospective, randomized, multicenter study conducted to determine whether the performance of an extended lymphadenectomy and retroperitoneal soft-tissue clearance in association with a pancreatoduodenal resection improves the long-term survival of patients with a potentially curable adenocarcinoma of the head of the pancreas. Although this study did not find any statistically significant difference in the long-term survival of patients undergoing a standard or an extended lymphadenectomy, the results suggest that patients who were node positive may benefit from a more aggressive oncologic clearance of the peripancreatic and retroperitoneal region. Because the procedure was not associated with greater morbidity or mortality, it should be considered in selected patients until further studies provide additional information on its selection and use.
